US502504A
(en)
|
|
1893-08-01 |
|
Hermann thoms |
DE487014C
(de)
|
1927-10-23 |
1929-12-09 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von Harnstoffderivaten
|
US1792156A
(en)
*
|
1928-01-17 |
1931-02-10 |
Gen Aniline Works Inc |
5-halogen-2-amino-1-alkyloxy and 1-aralkyloxy-benzenes and intermediate products thereof and process of preparing them
|
DE511468C
(de)
|
1928-01-18 |
1930-10-30 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor-2-amino-1-methoxybenzol
|
DE523437C
(de)
|
1928-12-25 |
1931-05-05 |
I G Farbenindustrie Akt Ges |
Verfahren zur Darstellung von 5-Chlor- und 5-Brom-2-amino-1-alkyloxy- und 1-aralkyloxybenzolen
|
US2093265A
(en)
|
1931-03-31 |
1937-09-14 |
Ici Ltd |
Process for the manufacture of diaryl ureas
|
US2046375A
(en)
|
1931-06-04 |
1936-07-07 |
Ici Ltd |
p-halogen-omicron-alkoxy-aniline derivatives and process of preparing the same
|
US2288422A
(en)
*
|
1938-11-11 |
1942-06-30 |
Gen Aniline & Film Corp |
Mixed ureas
|
US2973386A
(en)
*
|
1943-01-05 |
1961-02-28 |
Harry A Weldon |
Purification of sym dichloro-bis (2, 4, 6-trichlorophenyl)urea
|
US2502504A
(en)
*
|
1946-10-18 |
1950-04-04 |
John L Botner |
Hogshead
|
DE920245C
(de)
|
1950-04-29 |
1954-11-18 |
Variapat Ag |
Verfahren zur Herstellung von aromatischen, farblosen, wasserloeslichen Trifluormethyl- und Sulfosaeuregruppen enthaltenden unsymmetrischen Harnstoffen bzw. Thioharnstoffen
|
US2683082A
(en)
|
1950-12-09 |
1954-07-06 |
Ethyl Corp |
Nu-aryl-nu'-(p-hydroxyphenyl) ureas as antioxidants for petroleum hydrocarbon fuels
|
US2722544A
(en)
|
1950-12-26 |
1955-11-01 |
Variapat Ag |
Trifluoromethyl halogenated diphenylcarbamide sulfonic acids and their preparation
|
US2781330A
(en)
*
|
1953-02-09 |
1957-02-12 |
Monsanto Chemicals |
Rubber containing urea compound as an anti-exposure cracking agent
|
NL90162C
(ja)
*
|
1953-03-06 |
|
|
|
US2745874A
(en)
*
|
1953-06-18 |
1956-05-15 |
Geigy Ag J R |
Insecticidal derivatives of diphenyl urea
|
NL193403A
(ja)
*
|
1953-12-22 |
1924-02-17 |
|
|
GB771333A
(en)
|
1953-12-22 |
1957-03-27 |
Geigy Ag J R |
Improvements relating to halogen substituted diphenyl urea and thiourea compounds and their use
|
GB828231A
(en)
|
1955-10-20 |
1960-02-17 |
Geigy Ag J R |
Improvements relating to insecticidal compounds and their use
|
US2877268A
(en)
*
|
1956-12-24 |
1959-03-10 |
Monsanto Chemicals |
Substituted ureas
|
US2960488A
(en)
|
1958-04-25 |
1960-11-15 |
Eastman Kodak Co |
Poly-alpha-olefins containing substituted ureas
|
NL254871A
(ja)
*
|
1959-08-14 |
|
|
|
BE616734A
(ja)
|
1961-04-21 |
|
|
|
CH520657A
(de)
|
1961-09-11 |
1972-03-31 |
Wander Ag Dr A |
Verfahren zur Herstellung mehrbasischer Verbindungen
|
US3200035A
(en)
|
1962-06-01 |
1965-08-10 |
Ciba Ltd |
Treatment of synthetic products, especially synthetic fibers
|
US3284433A
(en)
|
1963-07-17 |
1966-11-08 |
Merck & Co Inc |
4-phenoxy-carbanilides
|
FR1457172A
(fr)
|
1964-12-12 |
1966-10-28 |
Ferrania Spa |
Procédé pour la production d'images photographiques en couleurs et matériel photographique correspondant
|
FR90420E
(ja)
|
1965-06-09 |
1968-02-21 |
|
|
US3424761A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3424762A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
Certain 3-ureidopyrrolidines
|
US3424760A
(en)
*
|
1966-03-07 |
1969-01-28 |
Robins Co Inc A H |
3-ureidopyrrolidines
|
US3547940A
(en)
|
1967-10-31 |
1970-12-15 |
Du Pont |
Substituted ureido isoxazoles
|
US3743498A
(en)
|
1967-10-31 |
1973-07-03 |
Du Pont |
Method of selectively controlling undesirable vegetation
|
SE370866B
(ja)
|
1968-03-21 |
1974-11-04 |
Ciba Geigy Ag |
|
DE1768244A1
(de)
|
1968-04-19 |
1971-10-14 |
Bayer Ag |
N-(2,2,4,4-Tetrafluor-1,3-benz-dioxanyl)-harnstoffe und Verfahren zu ihrer Herstellung
|
US3646059A
(en)
*
|
1969-05-05 |
1972-02-29 |
Du Pont |
Plant growth regulatory ureidopyrazoles
|
US3754887A
(en)
|
1969-05-05 |
1973-08-28 |
Du Pont |
Ureidopyrazoles defoliants
|
US3668222A
(en)
*
|
1969-05-14 |
1972-06-06 |
Sandoz Ltd |
11-desacetoxy-wortmannin
|
BE754782A
(fr)
|
1969-08-14 |
1971-02-12 |
May & Baker Ltd |
Derives du thiophene a action herbicide
|
US3823161A
(en)
|
1970-05-07 |
1974-07-09 |
Exxon Research Engineering Co |
Aminothiophene derivatives
|
US3860645A
(en)
*
|
1973-05-23 |
1975-01-14 |
Givaudan Corp |
Bacteriostatic substituted carbanilides
|
US4111680A
(en)
|
1973-07-27 |
1978-09-05 |
Shionogi & Co., Ltd. |
Herbicidal compositions containing 3-isoxazolylurea derivatives
|
US4212981A
(en)
|
1973-07-27 |
1980-07-15 |
Shionogi & Co., Ltd. |
Process for preparing 3-isoxazolylurea derivatives
|
JPS5031039A
(ja)
|
1973-07-27 |
1975-03-27 |
|
|
US4062861A
(en)
|
1973-07-27 |
1977-12-13 |
Shionogi & Co., Ltd. |
3-Isoxazolylurea derivatives
|
US4001256A
(en)
*
|
1973-12-26 |
1977-01-04 |
The Upjohn Company |
Pyridylalkyl phenyl ureas and their n-oxides
|
US3931201A
(en)
|
1974-01-22 |
1976-01-06 |
The Dow Chemical Company |
Substituted pyridinyloxy(thio)phenyl -acetamides, -ureas and urea derivatives
|
US4009847A
(en)
*
|
1974-04-17 |
1977-03-01 |
E. I. Du Pont De Nemours And Company |
1-Tertiary-alkyl-3-(substituted thienyl)ureas and 1-tertiary-alkyl-3-(substituted thietyl)ureas as antihypertensive agents
|
US3990879A
(en)
|
1974-12-26 |
1976-11-09 |
Eli Lilly And Company |
Method of controlling aquatic weeds
|
US4111683A
(en)
|
1975-06-27 |
1978-09-05 |
Chevron Research Company |
N-alkyl or alkoxy-N'-substituted hydrocarbyl urea
|
DE2637947C2
(de)
|
1976-08-24 |
1985-09-19 |
Bayer Ag, 5090 Leverkusen |
Tetrafluor-1,3-benzodioxanyl-benzoylharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Insektizide
|
JPS5840946B2
(ja)
|
1976-10-29 |
1983-09-08 |
石原産業株式会社 |
N−ベンゾイル−n′−ピリジルオキシフエニルウレア系化合物、それらの製造方法及びそれらを含有する殺虫剤
|
US4173637A
(en)
|
1976-10-29 |
1979-11-06 |
Ishihara Sangyo Kaisha Ltd. |
N-Benzoyl-N'-pyridyloxy phenyl urea and insecticidal compositions thereof
|
US4071524A
(en)
*
|
1976-11-08 |
1978-01-31 |
Riker Laboratories, Inc. |
Derivatives of urea
|
US4183854A
(en)
*
|
1976-11-10 |
1980-01-15 |
John Wyeth & Brother Limited |
Thiazole compound
|
US4042372A
(en)
|
1976-11-19 |
1977-08-16 |
Eli Lilly And Company |
Substituted thiadiazolotriazinediones and method of preparation
|
DE2817449A1
(de)
|
1978-04-21 |
1979-10-31 |
Bayer Ag |
Mittel zur regulierung des pflanzenwachstums
|
GB1590870A
(en)
|
1978-05-31 |
1981-06-10 |
Shionogi & Co |
N-(5-t-butyl-3-isoxazolyl) alkanamide derivatives having herbicidal activity
|
JPS5562066A
(en)
|
1978-11-03 |
1980-05-10 |
Toshihiko Okamoto |
N-(2-substituted-4-pyridyl)-urea and thio urea, their preparation and plant growth regulator
|
DE2848330A1
(de)
|
1978-11-03 |
1980-05-14 |
Schering Ag |
Verfahren zur herstellung von 1,2, 3-thiadiazol-5-yl-harnstoffen
|
FI800559A
(fi)
|
1979-03-14 |
1980-09-15 |
Hoffmann La Roche |
Urinaemnederivat
|
JPS55124763A
(en)
|
1979-03-19 |
1980-09-26 |
Ishihara Sangyo Kaisha Ltd |
5-trifluoromethyl-2-pyridone derivative
|
DE2928485A1
(de)
|
1979-07-14 |
1981-01-29 |
Bayer Ag |
Verwendung von harnstoffderivaten als arzneimittel bei der behandlung von fettstoffwechselstoerungen
|
US4468380A
(en)
|
1979-12-26 |
1984-08-28 |
Eli Lilly And Company |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
GB2080808B
(en)
|
1980-01-25 |
1984-01-04 |
Reanal Finomvegyszergyar |
Process for the preparation of n-aryl-n-(mono- or disubstituted)-urea derivatives
|
DE3165743D1
(de)
|
1980-05-14 |
1984-10-04 |
Ciba Geigy Ag |
Phenylbenzoyl urea
|
DE3174885D1
(en)
|
1981-02-03 |
1986-07-31 |
Ici Plc |
Process for the extraction of metal values and novel metal extractants
|
US4526997A
(en)
|
1981-05-06 |
1985-07-02 |
Doherty George O P O |
Anticoccidial combinations comprising polyether antibiotics and carbanilides
|
US4511571A
(en)
*
|
1981-10-20 |
1985-04-16 |
Ciba Geigy Corporation |
N-(2-Pyridyloxyphenyl)-N'-benzoyl ureas, pesticidal compositions containing same and pesticidal methods of use
|
US4473579A
(en)
|
1982-01-26 |
1984-09-25 |
American Cyanamid Company |
Antiatherosclerotic tetrasubstituted ureas and thioureas
|
US4623662A
(en)
|
1985-05-23 |
1986-11-18 |
American Cyanamid Company |
Antiatherosclerotic ureas and thioureas
|
DE3211851A1
(de)
*
|
1982-03-31 |
1983-10-06 |
Basf Ag |
Dihydrothiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
JPS58203957A
(ja)
*
|
1982-05-25 |
1983-11-28 |
Ube Ind Ltd |
尿素誘導体の製法
|
AU1862083A
(en)
|
1982-09-02 |
1984-03-08 |
Duphar International Research B.V. |
Tumor growth inhibitors
|
CA1254212A
(en)
*
|
1982-11-12 |
1989-05-16 |
Shiro Hirai |
Amine derivatives, salts thereof, process for preparing the same and an anti-ulcer agent containing the same
|
DE3305866A1
(de)
|
1983-02-19 |
1984-08-23 |
Basf Ag, 6700 Ludwigshafen |
Thiophen-carbonester, verfahren zu ihrer herstellung und ihre verwendung zur bekaempfung unerwuenschten pflanzenwuchses
|
US4499097A
(en)
|
1983-03-10 |
1985-02-12 |
American Cyanamid Company |
2-(Pyridyl)imidazolyl ketones
|
GB8325496D0
(en)
|
1983-09-23 |
1983-10-26 |
Hider R C |
Pharmaceutical compositions
|
CH663353A5
(de)
|
1984-03-28 |
1987-12-15 |
Joaquin Amat Larraz |
Mittel gegen krebs.
|
US4540566A
(en)
|
1984-04-02 |
1985-09-10 |
Forest Laboratories, Inc. |
Prolonged release drug dosage forms based on modified low viscosity grade hydroxypropylmethylcellulose
|
JPS6193163A
(ja)
|
1984-10-12 |
1986-05-12 |
Ishihara Sangyo Kaisha Ltd |
N−ベンゾイル−n′−フエニルウレア系化合物、それらの製造方法並びにそれらを含有する抗癌剤
|
US4727077A
(en)
|
1985-02-20 |
1988-02-23 |
Ishihara Sangyo Kaisha Ltd. |
Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
|
DE3529247A1
(de)
|
1985-05-17 |
1986-11-20 |
Bayer Ag, 5090 Leverkusen |
Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
|
DE3540377A1
(de)
|
1985-11-14 |
1987-05-21 |
Bayer Ag |
Thienooxazinone, verfahren zu ihrer herstellung und ihre verwendung als leistungsfoerderer
|
DE3541631A1
(de)
*
|
1985-11-26 |
1987-05-27 |
Bayer Ag |
Selektiv-fungizide verwendung von thienylharnstoff-derivaten
|
AU594098B2
(en)
|
1985-12-11 |
1990-03-01 |
Ishihara Sangyo Kaisha Ltd. |
N-benzoyl urea compounds, antitumorous compositions containing them, and process for their preparation
|
EP0230400A3
(de)
|
1986-01-21 |
1990-02-14 |
Ciba-Geigy Ag |
N-3-(5-Trifluormethyl-pyridyl-2-oxy)-phenyl-N'-benzoylharnstoffe zur Bekämpfung von Helminthen an Nutztieren
|
JPS62185013A
(ja)
|
1986-02-08 |
1987-08-13 |
Green Cross Corp:The |
易吸収性医薬組成物
|
DE3612830A1
(de)
|
1986-04-16 |
1987-10-22 |
Basf Ag |
Thiadiazolylharnstoff enthaltendes mittel zur entblaetterung von pflanzen
|
DE3785507T2
(de)
*
|
1986-07-31 |
1993-07-29 |
Beecham Group Plc |
Azabicyclische verbindungen, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung.
|
EP0262560A3
(en)
|
1986-09-29 |
1989-07-05 |
Ishihara Sangyo Kaisha, Ltd. |
Benzoyl urea compound
|
US4835180A
(en)
|
1986-10-02 |
1989-05-30 |
Sterling Drug Inc. |
N-(ω-cyanoalkyl)aminophenols and use as inhibitors of lipoxygenase activity
|
NZ221964A
(en)
*
|
1986-10-03 |
1990-03-27 |
Ishihara Sangyo Kaisha |
Benzoylurea compounds and insecticidal compositions
|
EP0264904A3
(en)
|
1986-10-23 |
1988-08-17 |
Ishihara Sangyo Kaisha, Ltd. |
Pharmaceutical compositions containing benzoyl urea derivatives
|
DE3636190A1
(de)
*
|
1986-10-24 |
1988-04-28 |
Bayer Ag |
Verfahren zur herstellung von n,n-diaryl-harnstoffen
|
JPH06100808B2
(ja)
|
1987-05-28 |
1994-12-12 |
富士写真フイルム株式会社 |
ハロゲン化銀カラ−写真感光材料の処理方法
|
ATE121742T1
(de)
|
1987-10-16 |
1995-05-15 |
Ciba Geigy Ag |
Schädlingsbekämpfungsmittel.
|
DE3810382A1
(de)
|
1988-03-26 |
1989-10-12 |
Bayer Ag |
5-amino-1-phenylpyrazole, verfahren sowie 5-halogen-1-phenylpyrazole als zwischenprodukte zu deren herstellung und ihre verwendung als herbizide
|
JP2791156B2
(ja)
|
1988-08-23 |
1998-08-27 |
ザ ヌトラスウィート カンパニー |
強力甘味料としての置換アリール尿素
|
JPH0278699A
(ja)
|
1988-09-12 |
1990-03-19 |
Green Cross Corp:The |
ベンゾイルウレア系化合物・アルブミン複合体
|
FR2662692B1
(fr)
|
1990-05-30 |
1995-04-28 |
Novapharme |
Derives heterocycliques doues d'activite anticonvulsivante, procede de preparation et composition pharmaceutique.
|
FR2639636B1
(fr)
|
1988-11-30 |
1994-03-04 |
Novapharme |
Nouveaux composes heterocycliques a activite anticonvulsivante, procede de preparation et compositions therapeutiques les contenant
|
JPH02196719A
(ja)
|
1989-01-24 |
1990-08-03 |
Green Cross Corp:The |
粉末状医薬組成物
|
JPH02237922A
(ja)
|
1989-01-24 |
1990-09-20 |
Green Cross Corp:The |
抗ウィルス剤
|
EP0379915A1
(de)
|
1989-01-26 |
1990-08-01 |
Bayer Ag |
Substituierte Phenoxybenzonitril-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Herbizide und Pflanzenwuchsregulatoren
|
JP3002204B2
(ja)
*
|
1989-03-13 |
2000-01-24 |
株式会社東芝 |
時系列信号認識装置
|
US4973675A
(en)
|
1989-04-13 |
1990-11-27 |
University Of Tennessee Research Center |
Hybrid nitrosoureidoanthracyclines having antitumor activity
|
JPH0395153A
(ja)
|
1989-06-15 |
1991-04-19 |
Mitsubishi Kasei Corp |
ジフェニル尿素誘導体
|
US5665543A
(en)
|
1989-07-18 |
1997-09-09 |
Oncogene Science, Inc. |
Method of discovering chemicals capable of functioning as gene expression modulators
|
IL95860A0
(en)
|
1989-10-13 |
1991-07-18 |
Ciba Geigy Ag |
Thienylthioureas,-isothioureas and-carbodiimides
|
EP0425443A1
(de)
|
1989-10-27 |
1991-05-02 |
Ciba-Geigy Ag |
Injizierbares parasitizides Mittel
|
DK40890D0
(da)
|
1990-02-16 |
1990-02-16 |
Ferrosan As |
Substituerede urinstofforbindelser, deres fremstilling og anvendelse
|
WO1991019697A1
(en)
*
|
1990-06-19 |
1991-12-26 |
Meiji Seika Kabushiki Kaisha |
Pyridine derivative with angiotensin ii antagonism
|
GB9017892D0
(en)
|
1990-08-15 |
1990-09-26 |
May & Baker Ltd |
New compositions of matter
|
ES2106855T3
(es)
*
|
1991-01-21 |
1997-11-16 |
Shionogi & Co |
Analogos de 3-benciliden-1-carbamoil-2-pirrolidona.
|
US5120842A
(en)
*
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
US5270458A
(en)
|
1991-04-02 |
1993-12-14 |
The Trustees Of Princeton University |
Nucleic acids encoding fragments of hematopoietic stem cell receptor flk-2
|
US5185438A
(en)
|
1991-04-02 |
1993-02-09 |
The Trustees Of Princeton University |
Nucleic acids encoding hencatoporetic stem cell receptor flk-2
|
US5100883A
(en)
*
|
1991-04-08 |
1992-03-31 |
American Home Products Corporation |
Fluorinated esters of rapamycin
|
US5118678A
(en)
*
|
1991-04-17 |
1992-06-02 |
American Home Products Corporation |
Carbamates of rapamycin
|
NO921449L
(no)
|
1991-04-17 |
1992-10-19 |
American Home Prod |
Karbamater av rapamycin
|
US5721237A
(en)
|
1991-05-10 |
1998-02-24 |
Rhone-Poulenc Rorer Pharmaceuticals Inc. |
Protein tyrosine kinase aryl and heteroaryl quinazoline compounds having selective inhibition of HER-2 autophosphorylation properties
|
US5118677A
(en)
*
|
1991-05-20 |
1992-06-02 |
American Home Products Corporation |
Amide esters of rapamycin
|
US5185358A
(en)
*
|
1991-06-24 |
1993-02-09 |
Warner-Lambert Co. |
3-heteroatom containing urea and thiourea ACAT inhibitors
|
US5162360A
(en)
|
1991-06-24 |
1992-11-10 |
Warner-Lambert Company |
2-heteroatom containing urea and thiourea ACAT inhibitors
|
AU2552492A
(en)
|
1991-08-23 |
1993-03-16 |
United States of America as represented by The Secretary Department of Health and Human Services, The |
Raf protein kinase therapeutics
|
US5151413A
(en)
|
1991-11-06 |
1992-09-29 |
American Home Products Corporation |
Rapamycin acetals as immunosuppressant and antifungal agents
|
US5254582A
(en)
|
1992-02-05 |
1993-10-19 |
Eli Lilly And Company |
Antitumor compositions and methods
|
US5508288A
(en)
*
|
1992-03-12 |
1996-04-16 |
Smithkline Beecham, P.L.C. |
Indole derivatives as 5HT1C antagonists
|
EP0642498A1
(en)
|
1992-05-28 |
1995-03-15 |
Pfizer Inc. |
NEW $i(N)-ARYL AND $i(N)-HETEROARYLUREA DERIVATIVES AS INHIBITORS OF ACYL COENZYME A:CHOLESTEROL ACYL TRANSFERASE (ACAT)
|
US5312820A
(en)
*
|
1992-07-17 |
1994-05-17 |
Merck & Co., Inc. |
Substituted carbamoyl and oxycarbonyl derivatives of biphenylmethylamines
|
US5256790A
(en)
|
1992-08-13 |
1993-10-26 |
American Home Products Corporation |
27-hydroxyrapamycin and derivatives thereof
|
JP2717481B2
(ja)
|
1992-08-25 |
1998-02-18 |
富士写真フイルム株式会社 |
ハロゲン化銀カラー写真感光材料
|
CN2146707Y
(zh)
|
1992-09-08 |
1993-11-17 |
华东冶金学院 |
高炉软水冷却***检漏装置
|
US5258389A
(en)
|
1992-11-09 |
1993-11-02 |
Merck & Co., Inc. |
O-aryl, O-alkyl, O-alkenyl and O-alkynylrapamycin derivatives
|
US6177401B1
(en)
|
1992-11-13 |
2001-01-23 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften |
Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis
|
WO1994014801A1
(en)
|
1992-12-29 |
1994-07-07 |
Smithkline Beecham Plc |
Heterocyclic urea derivatives as 5ht2c and 5ht2b antagonists
|
US5512473A
(en)
|
1993-01-29 |
1996-04-30 |
Brent; Roger |
Max-interacting proteins and related molecules and methods
|
GB9302275D0
(en)
|
1993-02-05 |
1993-03-24 |
Smithkline Beecham Plc |
Novel compounds
|
TW272942B
(ja)
|
1993-02-10 |
1996-03-21 |
Takeda Pharm Industry Co Ltd |
|
DK41193D0
(da)
|
1993-04-07 |
1993-04-07 |
Neurosearch As |
Ionkanalaabnere
|
DE4322806A1
(de)
|
1993-07-08 |
1995-01-12 |
Janich Gmbh & Co |
Vorrichtung zur Abdichtung zwischen zwei Anlagenteilen
|
IL110296A
(en)
|
1993-07-16 |
1999-12-31 |
Smithkline Beecham Corp |
Imidazole compounds process for their preparation and pharmaceutical compositions containing them
|
US6514745B1
(en)
|
1993-07-19 |
2003-02-04 |
The Regents Of The University Of California |
Oncoprotein protein kinase
|
US5378725A
(en)
*
|
1993-07-19 |
1995-01-03 |
The Arizona Board Of Regents |
Inhibition of phosphatidylinositol 3-kinase with wortmannin and analogs thereof
|
NZ264063A
(en)
*
|
1993-08-13 |
1995-11-27 |
Nihon Nohyaku Co Ltd |
N-(2-phenylpyrid-3-yl)- and n-(4-phenylpyrimidin-5-yl)-n'-phenylurea derivatives and pharmaceutical compositions
|
US5504103A
(en)
*
|
1993-08-25 |
1996-04-02 |
Eli Lilly And Company |
Inhibition of phosphatidylinositol 3-kinase with 17 β-hydroxywortmannin and analogs thereof
|
US5468773A
(en)
|
1993-08-25 |
1995-11-21 |
Eli Lilly And Company |
Methods for inhibiting bone loss and cartilage degradation using wortmannin and its analogs
|
US5441947A
(en)
|
1993-08-25 |
1995-08-15 |
Eli Lilly And Company |
Methods of inhibiting vascular restenosis
|
DE69421624T2
(de)
|
1993-09-17 |
2000-07-20 |
Smithkline Beecham Corp |
Medikamente bindendes protein
|
US5869043A
(en)
|
1993-09-17 |
1999-02-09 |
Smithkline Beecham Corporation |
Drug binding protein
|
US6361773B1
(en)
|
1993-09-17 |
2002-03-26 |
Smithkline Beecham Corporation |
Antibodies produced against cytokine suppressive anti-inflammatory drug binding proteins
|
US5783664A
(en)
|
1993-09-17 |
1998-07-21 |
Smithkline Beecham Corporation |
Cytokine suppressive anit-inflammatory drug binding proteins
|
US5547966A
(en)
|
1993-10-07 |
1996-08-20 |
Bristol-Myers Squibb Company |
Aryl urea and related compounds
|
CA2133815A1
(en)
*
|
1993-10-12 |
1995-04-13 |
Jeffrey Alan Dodge |
Inhibition of phosphatidylinositol 3-kinase with viridin, demethoxyviridin, viridiol, demethoxyviridiol, virone, wortmannolone, and analogs thereof
|
US5596001A
(en)
*
|
1993-10-25 |
1997-01-21 |
Pfizer Inc. |
4-aryl-3-(heteroarylureido)quinoline derivatves
|
EP1306377A3
(en)
|
1993-11-08 |
2003-05-07 |
Smithkline Beecham Corporation |
Pyridyl-oxazoles and their use as cytokines inhibitors
|
JPH07141053A
(ja)
|
1993-11-17 |
1995-06-02 |
Nec Niigata Ltd |
クロック発生回路
|
US5700823A
(en)
|
1994-01-07 |
1997-12-23 |
Sugen, Inc. |
Treatment of platelet derived growth factor related disorders such as cancers
|
CH686211A5
(de)
*
|
1994-01-27 |
1996-02-15 |
Ciba Geigy Ag |
Motten- und Koferschutzmittel.
|
US6524832B1
(en)
|
1994-02-04 |
2003-02-25 |
Arch Development Corporation |
DNA damaging agents in combination with tyrosine kinase inhibitors
|
US6811779B2
(en)
*
|
1994-02-10 |
2004-11-02 |
Imclone Systems Incorporated |
Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapy
|
DE4412334A1
(de)
|
1994-04-11 |
1995-10-19 |
Hoechst Ag |
Substituierte N-Heteroaroylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
|
US5559137A
(en)
|
1994-05-16 |
1996-09-24 |
Smithkline Beecham Corp. |
Compounds
|
US5744362A
(en)
|
1994-05-31 |
1998-04-28 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5656612A
(en)
|
1994-05-31 |
1997-08-12 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of raf gene expression
|
US5447957A
(en)
|
1994-06-02 |
1995-09-05 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
WO1995033458A1
(en)
|
1994-06-02 |
1995-12-14 |
Smithkline Beecham Corporation |
Anti-inflammatory compounds
|
US5470882A
(en)
|
1994-06-02 |
1995-11-28 |
Smithkline Beecham Corp. |
Anti-inflammatory compounds
|
US5786362A
(en)
|
1994-06-16 |
1998-07-28 |
University Of Miami |
Method of treating Hormone independent cancer
|
EP0690344A1
(en)
|
1994-06-29 |
1996-01-03 |
Konica Corporation |
Silver halide color photographic light-sensitive material
|
US5480906A
(en)
*
|
1994-07-01 |
1996-01-02 |
Eli Lilly And Company |
Stereochemical Wortmannin derivatives
|
FR2722319B1
(fr)
|
1994-07-08 |
1996-08-14 |
Thomson Csf |
Dispositif de visualisation couleurs
|
US5597719A
(en)
*
|
1994-07-14 |
1997-01-28 |
Onyx Pharmaceuticals, Inc. |
Interaction of RAF-1 and 14-3-3 proteins
|
AU3577995A
(en)
|
1994-10-04 |
1996-04-26 |
Fujisawa Pharmaceutical Co., Ltd. |
Urea derivatives and their use as acat-inhibitors
|
PT708085E
(pt)
|
1994-10-19 |
2002-11-29 |
Novartis Ag |
Eteres antivirais de isosteros de substrato de aspartato protease
|
CA2161376C
(en)
|
1994-10-27 |
2005-01-11 |
Toshiaki Minami |
Reversible multi-color thermal recording medium
|
ATE201243T1
(de)
|
1994-10-28 |
2001-06-15 |
Novozymes As |
Verfahren zur chemischen ausrüstung von unlöslichen polymerfasern
|
TW313568B
(ja)
|
1994-12-20 |
1997-08-21 |
Hoffmann La Roche |
|
FR2729567B1
(fr)
*
|
1995-01-20 |
1997-06-13 |
Oreal |
Composition de teinture d'oxydation des fibres keratiniques et procede de teinture mettant en oeuvre cette composition
|
EP0809492A4
(en)
|
1995-02-17 |
2007-01-24 |
Smithkline Beecham Corp |
IL-8 RECEPTOR ANTAGONISTS
|
US5780483A
(en)
|
1995-02-17 |
1998-07-14 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US5624937A
(en)
|
1995-03-02 |
1997-04-29 |
Eli Lilly And Company |
Chemical compounds as inhibitors of amyloid beta protein production
|
US5814646A
(en)
|
1995-03-02 |
1998-09-29 |
Eli Lilly And Company |
Inhibitors of amyloid beta-protein production
|
DE19512639A1
(de)
|
1995-04-05 |
1996-10-10 |
Merck Patent Gmbh |
Benzonitrile und -fluoride
|
US5747498A
(en)
|
1996-05-28 |
1998-05-05 |
Pfizer Inc. |
Alkynyl and azido-substituted 4-anilinoquinazolines
|
US5658903A
(en)
|
1995-06-07 |
1997-08-19 |
Smithkline Beecham Corporation |
Imidazole compounds, compositions and use
|
US5710173A
(en)
|
1995-06-07 |
1998-01-20 |
Sugen, Inc. |
Thienyl compounds for inhibition of cell proliferative disorders
|
US5773459A
(en)
|
1995-06-07 |
1998-06-30 |
Sugen, Inc. |
Urea- and thiourea-type compounds
|
US5849761A
(en)
|
1995-09-12 |
1998-12-15 |
Regents Of The University Of California |
Peripherally active anti-hyperalgesic opiates
|
ZA967840B
(en)
*
|
1995-09-18 |
1997-04-07 |
Sankyo Co |
New urea derivatives having a cat inhibitory activity their preparation and their therapeutic and prophylactic use
|
US6075040A
(en)
|
1996-09-05 |
2000-06-13 |
Eli Lilly And Company |
Selective β3 adrenergic agonists
|
SE510846C2
(sv)
|
1995-11-06 |
1999-06-28 |
Moelnlycke Health Care Ab |
Innerförpackning för i en yttre förpackning sterilförpackade bukdukar
|
WO1997017329A1
(fr)
|
1995-11-07 |
1997-05-15 |
Kirin Beer Kabushiki Kaisha |
Derives de quinoline et derives de quinazoline inhibant l'autophosphorylation d'un recepteur de facteur de croissance originaire de plaquettes, et compositions pharmaceutiques les contenant
|
WO1997024330A1
(fr)
*
|
1995-12-28 |
1997-07-10 |
Kureha Kagaku Kogyo Kabushiki Kaisha |
Nouveaux n-(non substitue ou substitue)-4-substitue-6-(non substitue ou substitue) phenoxy-2-pyridinecarboxamides ou thiocarboxamides, leurs procedes de production, et herbicides
|
US5807876A
(en)
|
1996-04-23 |
1998-09-15 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6005008A
(en)
|
1996-02-16 |
1999-12-21 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
US6011029A
(en)
|
1996-02-26 |
2000-01-04 |
Bristol-Myers Squibb Company |
Inhibitors of farnesyl protein transferase
|
US6103692A
(en)
|
1996-03-12 |
2000-08-15 |
The General Hospital Corporation |
Inhibiting protein interactions
|
US6211373B1
(en)
*
|
1996-03-20 |
2001-04-03 |
Smithkline Beecham Corporation |
Phenyl urea antagonists of the IL-8 receptor
|
US6262113B1
(en)
|
1996-03-20 |
2001-07-17 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
EP0802187B1
(en)
*
|
1996-04-15 |
2000-02-16 |
Takeda Chemical Industries, Ltd. |
Hydroxypyridine derivatives, their production and their pharmaceutical use
|
EA004771B1
(ru)
|
1996-04-23 |
2004-08-26 |
Вертекс Фармасьютикалз Инкорпорейтед |
Производные мочевины и их применение в качестве ингибиторов инозин-5`-монофосфат- дегидрогеназы
|
US6232299B1
(en)
|
1996-05-01 |
2001-05-15 |
Eli Lilly And Company |
Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy
|
JPH09301858A
(ja)
|
1996-05-13 |
1997-11-25 |
Senju Pharmaceut Co Ltd |
グルコン酸クロルヘキシジン安定化水性薬剤
|
US6417393B1
(en)
|
1996-05-24 |
2002-07-09 |
Neurosearch A/S |
Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
|
US5910417A
(en)
|
1996-05-31 |
1999-06-08 |
National Jewish Center For Immunology And Respiratory Medicine |
Regulation of cytokine production in a hematopoietic cell
|
WO1997049399A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
WO1997049286A1
(en)
|
1996-06-27 |
1997-12-31 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
EP0932405A4
(en)
|
1996-06-27 |
2001-10-17 |
Smithkline Beckman Corp |
IL-8 RECEPTOR ANTAGONISTS
|
AU3409197A
(en)
|
1996-06-27 |
1998-01-14 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
US6150415A
(en)
|
1996-08-13 |
2000-11-21 |
The Regents Of The University Of California |
Epoxide hydrolase complexes and methods therewith
|
US6019793A
(en)
|
1996-10-21 |
2000-02-01 |
Synthes |
Surgical prosthetic device
|
EP0973513A4
(en)
|
1996-10-23 |
2003-03-19 |
Zymogenetics Inc |
COMPOSITIONS AND METHODS FOR TREATING CONDITIONS ASSOCIATED WITH BONE DEFICIT
|
US5965573A
(en)
|
1996-10-23 |
1999-10-12 |
Zymogenetics, Inc. |
Compositions and methods for treating bone deficit conditions
|
DE69739734D1
(de)
|
1996-11-15 |
2010-02-25 |
Cytokine Pharmasciences Inc |
Guanylhydrazone die nützlich sind zur behandlung von mit t-zellen verbundenen krankheiten
|
GB9623833D0
(en)
|
1996-11-16 |
1997-01-08 |
Zeneca Ltd |
Chemical compound
|
AU4966497A
(en)
|
1996-11-18 |
1998-06-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel acylamino-substituted acylanilide derivatives or pharmaceutical composition comprising the same
|
FR2755967B1
(fr)
*
|
1996-11-21 |
1999-01-29 |
Pf Medicament |
Derives de la pyridin-2-yl-methylamine, leur procede de preparation et leur application comme medicaments
|
US5929250A
(en)
*
|
1997-01-23 |
1999-07-27 |
Smithkline Beecham Corporation |
IL-8 receptor antagonists
|
TR199901710T2
(xx)
|
1997-01-23 |
1999-09-21 |
Smithkline Beecham Corporation |
IL-8 resept�r antagonistleri.
|
DE19706061A1
(de)
|
1997-02-07 |
1998-08-13 |
Schering Ag |
Antigestagen wirksame Steroide mit fluorierter 17alpha-Alkylkette
|
AU6435098A
(en)
|
1997-02-12 |
1998-08-26 |
Smithkline Beecham Corporation |
Il-8 receptor antagonists
|
NZ337698A
(en)
|
1997-04-04 |
2001-07-27 |
Pfizer Prod Inc |
Nicotinamide derivatives for selective inhibition of phosphodiesterase type 4 (PDE4) and the production of tumour necrosis factor (TNF) useful for the treatment of respiratory, rheumatoid and allergic diseases
|
AU6783698A
(en)
|
1997-04-10 |
1998-10-30 |
Pharmacia & Upjohn Company |
Polyaromatic antiviral compositions
|
AU7080298A
(en)
|
1997-04-25 |
1998-11-24 |
Takeda Chemical Industries Ltd. |
Triazine derivatives, their production and agrochemical composition
|
US6210710B1
(en)
|
1997-04-28 |
2001-04-03 |
Hercules Incorporated |
Sustained release polymer blend for pharmaceutical applications
|
AR012634A1
(es)
|
1997-05-02 |
2000-11-08 |
Sugen Inc |
Compuesto basado en quinazolina, composicion famaceutica que lo comprende, metodo para sintetizarlo, su uso, metodos de modulacion de la funcion deserina/treonina proteinaquinasa con dicho compuesto y metodo in vitro para identificar compuestos que modulan dicha funcion
|
US6316479B1
(en)
*
|
1997-05-19 |
2001-11-13 |
Sugen, Inc. |
Isoxazole-4-carboxamide compounds active against protein tryosine kinase related disorders
|
AU7726898A
(en)
|
1997-05-22 |
1998-12-11 |
G.D. Searle & Co. |
Pyrazole derivatives as p38 kinase inhibitors
|
WO1998052937A2
(en)
|
1997-05-22 |
1998-11-26 |
G.D. Searle And Co. |
4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
|
US6514977B1
(en)
|
1997-05-22 |
2003-02-04 |
G.D. Searle & Company |
Substituted pyrazoles as p38 kinase inhibitors
|
US6187799B1
(en)
|
1997-05-23 |
2001-02-13 |
Onyx Pharmaceuticals |
Inhibition of raf kinase activity using aryl ureas
|
DE69839639D1
(en)
|
1997-05-23 |
2008-08-07 |
Bayer Pharmaceuticals Corp |
Raf kinase hemmer
|
WO1998052558A1
(en)
|
1997-05-23 |
1998-11-26 |
Bayer Corporation |
INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
|
US6344476B1
(en)
|
1997-05-23 |
2002-02-05 |
Bayer Corporation |
Inhibition of p38 kinase activity by aryl ureas
|
US6150395A
(en)
|
1997-05-30 |
2000-11-21 |
The Regents Of The University Of California |
Indole-3-carbinol (I3C) derivatives and methods
|
US6294350B1
(en)
|
1997-06-05 |
2001-09-25 |
Dalhousie University |
Methods for treating fibroproliferative diseases
|
US5985592A
(en)
|
1997-06-05 |
1999-11-16 |
Dalhousie University |
Uses for pentoxifylline or functional derivatives/metabolites thereof
|
US20020156104A1
(en)
|
1997-06-13 |
2002-10-24 |
Jerry L. Adams |
Novel pyrazole and pyrazoline substituted compounds
|
EP1020444A4
(en)
|
1997-06-27 |
2001-04-11 |
Kureha Chemical Ind Co Ltd |
6-PHENOXYPICOLINIC ACID, ALKYLIDENEHYDRAZIDE DERIVATIVES, THEIR PRODUCTION PROCESS, AND HERBICIDE
|
US6093742A
(en)
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
US6525065B1
(en)
|
1997-06-30 |
2003-02-25 |
Targacept, Inc. |
Pharmaceutical compositions and methods for effecting dopamine release
|
AUPP003197A0
(en)
|
1997-09-03 |
1997-11-20 |
Fujisawa Pharmaceutical Co., Ltd. |
New heterocyclic compounds
|
UA71555C2
(en)
|
1997-10-06 |
2004-12-15 |
Zentaris Gmbh |
Methods for modulating function of serine/threonine protein kinases by 5-azaquinoline derivatives
|
AU9802198A
(en)
|
1997-10-21 |
1999-05-10 |
Pharmacia & Upjohn Company |
Antiinflammatory thiadiazolyl ureas which act as lfa-1 and mac-1 inhibitors
|
KR20010031557A
(ko)
|
1997-10-31 |
2001-04-16 |
추후제출 |
치환 아닐리드
|
JP2001521934A
(ja)
|
1997-11-03 |
2001-11-13 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症薬としての芳香族ヘテロ環式化合物
|
US6022884A
(en)
|
1997-11-07 |
2000-02-08 |
Amgen Inc. |
Substituted pyridine compounds and methods of use
|
US6018065A
(en)
|
1997-11-10 |
2000-01-25 |
Advanced Technology Materials, Inc. |
Method of fabricating iridium-based materials and structures on substrates, iridium source reagents therefor
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
WO1999026657A1
(en)
|
1997-11-25 |
1999-06-03 |
Musc Foundation For Research Development |
Inhibitors of nitric oxide synthase
|
AU1407899A
(en)
|
1997-12-01 |
1999-06-16 |
E.I. Du Pont De Nemours And Company |
Fungicidal cyclic amides
|
US6635421B1
(en)
|
1997-12-09 |
2003-10-21 |
Children's Medical Center Corporation |
Neuropilins and use thereof in methods for diagnosis and prognosis of cancer
|
SK282727B6
(sk)
|
1997-12-19 |
2002-11-06 |
Slovakofarma, A. S. |
1,3-Disubstituované močoviny - inhibítory ACAT a spôsob ich prípravy
|
US6174901B1
(en)
*
|
1998-12-18 |
2001-01-16 |
Amgen Inc. |
Substituted pyridine and pyridazine compounds and methods of use
|
DK1043995T3
(da)
|
1997-12-22 |
2007-03-05 |
Bayer Pharmaceuticals Corp |
Inhibering af p38 kinaseaktivitet ved anvendelse af aryl- og heteroaryl-substituerede, heterocykliske urinstoffer
|
IL136738A0
(en)
|
1997-12-22 |
2001-06-14 |
Bayer Ag |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
US7517880B2
(en)
*
|
1997-12-22 |
2009-04-14 |
Bayer Pharmaceuticals Corporation |
Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
|
BR9814361A
(pt)
|
1997-12-22 |
2001-11-27 |
Bayer Ag |
Inibição de quinase raf usando uréiasheterocìclicas substituìdas por arila eheteroarila
|
ATE297383T1
(de)
|
1997-12-22 |
2005-06-15 |
Bayer Pharmaceuticals Corp |
Hemmung der p38 kinase unter verwendung von symmetrischen und asymmetrischen diphenylharnstoffen
|
US20120046290A1
(en)
|
1997-12-22 |
2012-02-23 |
Jacques Dumas |
Inhibition of p38 kinase activity using substituted heterocyclic ureas
|
CZ299156B6
(cs)
|
1997-12-22 |
2008-05-07 |
Bayer Corporation |
Substituované heterocyklické mocoviny, farmaceutické prípravky je obsahující a jejich použití
|
US20080300281A1
(en)
|
1997-12-22 |
2008-12-04 |
Jacques Dumas |
Inhibition of p38 Kinase Activity Using Aryl and Heteroaryl Substituted Heterocyclic Ureas
|
US20070244120A1
(en)
|
2000-08-18 |
2007-10-18 |
Jacques Dumas |
Inhibition of raf kinase using substituted heterocyclic ureas
|
US7329670B1
(en)
*
|
1997-12-22 |
2008-02-12 |
Bayer Pharmaceuticals Corporation |
Inhibition of RAF kinase using aryl and heteroaryl substituted heterocyclic ureas
|
WO1999032436A1
(en)
|
1997-12-22 |
1999-07-01 |
Bayer Corporation |
Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
|
WO1999033458A1
(fr)
|
1997-12-25 |
1999-07-08 |
Daiichi Pharmaceutical Co., Ltd. |
Composition medicinale pour administration percutanee
|
US6221913B1
(en)
*
|
1998-01-21 |
2001-04-24 |
Zymogenetics, Inc. |
Dialkyl ureas as calcitonin mimetics
|
FR2774824B1
(fr)
|
1998-02-09 |
2000-04-28 |
Moving Magnet Tech |
Actionneur lineaire ameliore
|
AU749180B2
(en)
|
1998-02-18 |
2002-06-20 |
Theryte Limited |
Treating cancer
|
MY132496A
(en)
|
1998-05-11 |
2007-10-31 |
Vertex Pharma |
Inhibitors of p38
|
US6413773B1
(en)
*
|
1998-06-01 |
2002-07-02 |
The Regents Of The University Of California |
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
|
UA60365C2
(uk)
|
1998-06-04 |
2003-10-15 |
Пфайзер Продактс Інк. |
Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
|
US6667340B1
(en)
|
1998-06-26 |
2003-12-23 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Inhibitors of phosphatidyl myo-inositol cycle
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
WO2000017175A1
(en)
|
1998-09-18 |
2000-03-30 |
Vertex Pharmaceuticals Incorporated |
INHIBITORS OF p38
|
US6383734B1
(en)
|
1998-09-30 |
2002-05-07 |
Advanced Research And Technology Institute, Inc. |
Method to determine inhibition of PAK3 activation of Raf-1
|
US6130053A
(en)
|
1999-08-03 |
2000-10-10 |
Cell Pathways, Inc. |
Method for selecting compounds for inhibition of neoplastic lesions
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
TR200102278T2
(tr)
|
1998-11-06 |
2001-12-21 |
Basf Aktiengesellschaft |
Vasküler hiperpermeabilite oluşumunun önlenmesi.
|
AU2156600A
(en)
|
1998-11-25 |
2000-06-13 |
Cold Spring Harbor Laboratory |
Methods and reagents for increasing proliferative capacity and preventing replicative senescence
|
US6114517A
(en)
|
1998-12-10 |
2000-09-05 |
Isis Pharmaceuticals Inc. |
Methods of modulating tumor necrosis factor α-induced expression of cell adhesion molecules
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
UY25842A1
(es)
|
1998-12-16 |
2001-04-30 |
Smithkline Beecham Corp |
Antagonistas de receptores de il-8
|
US6331541B1
(en)
|
1998-12-18 |
2001-12-18 |
Soo S. Ko |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
WO2000035454A1
(en)
|
1998-12-18 |
2000-06-22 |
Du Pont Pharmaceuticals Company |
N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
|
US6147107A
(en)
|
1998-12-20 |
2000-11-14 |
Virginia Commonwealth University |
Specific inhibition of the P42/44 mitogen activated protein (map) kinase cascade sensitizes tumor cells
|
US20080269265A1
(en)
|
1998-12-22 |
2008-10-30 |
Scott Miller |
Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas
|
EP1142890B1
(en)
|
1998-12-25 |
2005-08-03 |
Teikoku Hormone Mfg. Co., Ltd. |
Aminopyrazole derivatives
|
ME00275B
(me)
|
1999-01-13 |
2011-02-10 |
Bayer Corp |
ω-KARBOKSIARIL SUPSTITUISANI DIFENIL KARBAMIDI KAO INHIBITORI RAF KINAZE
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US20020065296A1
(en)
|
1999-01-13 |
2002-05-30 |
Bayer Corporation |
Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors
|
ATE538794T1
(de)
*
|
1999-01-13 |
2012-01-15 |
Bayer Healthcare Llc |
Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer
|
WO2000042012A1
(en)
|
1999-01-13 |
2000-07-20 |
Bayer Corporation |
φ-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS RAF KINASE INHIBITORS
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
TWI284642B
(en)
|
1999-01-18 |
2007-08-01 |
Hoffmann La Roche |
Novel heterocyclic sulfonamides
|
UA73492C2
(en)
|
1999-01-19 |
2005-08-15 |
|
Aromatic heterocyclic compounds as antiinflammatory agents
|
EP1153920B1
(en)
|
1999-01-22 |
2003-10-29 |
Kirin Beer Kabushiki Kaisha |
Quinoline derivatives and quinazoline derivatives
|
EP1150977B1
(en)
|
1999-02-12 |
2004-08-25 |
SmithKline Beecham plc |
Phenyl urea and phenyl thiourea derivatives as orexin receptor antagonists
|
MXPA01008440A
(es)
|
1999-02-22 |
2002-04-24 |
Boehringer Ingelheim Pharma |
Derivados heterociclicos policiclos como agentes anti-inflamatorios..
|
JP2002539206A
(ja)
|
1999-03-12 |
2002-11-19 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
抗炎症剤としての芳香族複素環化合物
|
US6358945B1
(en)
*
|
1999-03-12 |
2002-03-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
PL211562B1
(pl)
|
1999-03-19 |
2012-05-31 |
Vertex Pharma |
Związki, zawierające je kompozycje oraz ich zastosowania
|
ATE467620T1
(de)
|
1999-03-26 |
2010-05-15 |
Euro Celtique Sa |
Arylsubstituierte pyrazole, imidazole, oxazole, thiazole und pyrrole, sowie deren verwendung
|
US6140124A
(en)
|
1999-04-06 |
2000-10-31 |
Isis Pharmaceuticals Inc. |
Antisense modulation of P38 mitogen activated protein kinase expression
|
US6316462B1
(en)
|
1999-04-09 |
2001-11-13 |
Schering Corporation |
Methods of inducing cancer cell death and tumor regression
|
ATE263162T1
(de)
|
1999-05-05 |
2004-04-15 |
Aventis Pharma Ltd |
Harnstoffderivate und ihr gebrauch als zell adhesion modulatoren
|
RU2294761C2
(ru)
|
1999-05-14 |
2007-03-10 |
Имклон Систимс Инкопэритид |
Лечение резистентных опухолей человека антагонистами рецепторов фактора роста эпидермиса
|
HN2000000051A
(es)
|
1999-05-19 |
2001-02-02 |
Pfizer Prod Inc |
Derivados heterociclicos utiles como agentes anticancerosos
|
TWI234557B
(en)
|
1999-05-26 |
2005-06-21 |
Telik Inc |
Novel naphthalene ureas as glucose uptake enhancers
|
DE19927835A1
(de)
|
1999-06-18 |
2000-12-21 |
Clariant Gmbh |
Verwendung von verbesserten Cyanpigmenten in elektrophotographischen Tonern und Entwicklern, Pulverlacken und Ink-Jet-Tinten
|
CA2374737C
(en)
|
1999-07-09 |
2008-02-12 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Novel process for synthesis of heteroaryl-substituted urea compounds
|
US6483451B1
(en)
|
1999-07-09 |
2002-11-19 |
Yasue Sakai |
Sampling function waveform data generating device
|
DE60024631T2
(de)
|
1999-07-26 |
2006-06-14 |
Banyu Pharma Co Ltd |
Biaryl-harnstoff-derivate
|
AU6339200A
(en)
|
1999-07-28 |
2001-02-19 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
US6387900B1
(en)
|
1999-08-12 |
2002-05-14 |
Pharmacia & Upjohn S.P.A. |
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents
|
US6372933B1
(en)
|
1999-08-26 |
2002-04-16 |
Smithkline Beecham Corporation |
Process for preparing certain phenyl urea compounds
|
CA2383626A1
(en)
|
1999-10-15 |
2001-08-02 |
Bobby G. Edwards |
Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
|
MXPA02004594A
(es)
|
1999-11-16 |
2002-10-23 |
Boehringer Ingelheim Pharma |
Derivados de urea como agentes anti-inflamatorios.
|
US6525046B1
(en)
*
|
2000-01-18 |
2003-02-25 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Aromatic heterocyclic compounds as antiinflammatory agents
|
US7740841B1
(en)
|
2000-01-28 |
2010-06-22 |
Sunnybrook Health Science Center |
Therapeutic method for reducing angiogenesis
|
WO2001057008A1
(en)
|
2000-02-07 |
2001-08-09 |
Abbott Gesellschaft Mit Beschrankter Haftung & Company Kommanditgesellschaft |
2-benzothiazolyl urea derivatives and their use as protein kinase inhibitors
|
US6608052B2
(en)
|
2000-02-16 |
2003-08-19 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
AU4194601A
(en)
|
2000-03-02 |
2001-09-12 |
Ludwig Institute For Cancer Research |
Methods for treating, screening for, and detecting cancers expressing vascular endothelial growth factor
|
GB0005357D0
(en)
|
2000-03-06 |
2000-04-26 |
Smithkline Beecham Plc |
Compounds
|
BR0110310A
(pt)
|
2000-04-19 |
2003-02-18 |
Fujisawa Pharmaceutical Co |
Dispersão sólida, processo para sua produção e preparado farmacêutico contendo a mesma
|
US6667300B2
(en)
|
2000-04-25 |
2003-12-23 |
Icos Corporation |
Inhibitors of human phosphatidylinositol 3-kinase delta
|
US6403588B1
(en)
|
2000-04-27 |
2002-06-11 |
Yamanouchi Pharmaceutical Co., Ltd. |
Imidazopyridine derivatives
|
WO2002007008A1
(en)
|
2000-04-28 |
2002-01-24 |
Ubink Cornelis Hubertus Johann |
Network procurement system
|
US6390102B1
(en)
|
2000-07-14 |
2002-05-21 |
General Electric Company |
Silicone compositions for personal care products and method for making
|
WO2002007747A1
(en)
|
2000-07-18 |
2002-01-31 |
Joslin Diabetes Center, Inc. |
Methods of modulating fibrosis
|
JP2004504360A
(ja)
|
2000-07-24 |
2004-02-12 |
ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド |
1−(5−tert−ブチル−2−P−トリル−2H−ピラゾール−3−イル)−3−[4−(2−モルホリン−4−イル−エトキシ)−ナフタレン−1−イル]−ウレアの改良された経口製剤
|
GT200100147A
(es)
|
2000-07-31 |
2002-06-25 |
|
Derivados de imidazol
|
RU2003105882A
(ru)
|
2000-08-04 |
2005-01-20 |
Лома Линда Юниверсити Медикал Сентер (Us) |
Упорядоченный железосодержащий белок-2 в качестве диагностического средства при нейродегенеративных заболеваниях
|
JP4993838B2
(ja)
|
2000-08-11 |
2012-08-08 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
P38のインヒビターとしてのピリジン誘導体
|
US20020173507A1
(en)
|
2000-08-15 |
2002-11-21 |
Vincent Santora |
Urea compounds and methods of uses
|
KR20040074096A
(ko)
|
2000-08-17 |
2004-08-21 |
샤단호칭키타사토겐큐쇼 |
신규 슈도에리쓰로마이신 유도체
|
PL360742A1
(en)
|
2000-08-31 |
2004-09-20 |
Pfizer Products Inc. |
Pyrazole derivatives and their use as protein kinase inhibitors
|
AUPR034000A0
(en)
|
2000-09-25 |
2000-10-19 |
Fujisawa Pharmaceutical Co., Ltd. |
Aminoalcohol derivatives
|
ES2282299T3
(es)
|
2000-10-20 |
2007-10-16 |
EISAI R&D MANAGEMENT CO., LTD. |
Compuestos aromaticos con anillos de nitrogeno como agentes anticancerigenos.
|
JP3768800B2
(ja)
|
2000-10-31 |
2006-04-19 |
キヤノン株式会社 |
画像形成装置
|
AU2002223500A1
(en)
|
2000-11-17 |
2002-05-27 |
Novo-Nordisk A/S |
Glucagon antagonists/inverse agonists
|
CA2429846A1
(en)
|
2000-11-27 |
2002-05-30 |
Eric A. Brill |
System, method, and program for sorting objects
|
DOP2001000288A
(es)
|
2000-11-28 |
2002-12-15 |
Pfizer Prod Inc |
Formas de sal de amida de acido3-(4-bromo-2,6-difluoro-benciloxi)-5-(3-(4-pirrolidin - 1 - ilbutil) ureidoisitiazol - 4 - carboxilico y método de producción
|
EP1341771A2
(en)
|
2000-11-29 |
2003-09-10 |
Glaxo Group Limited |
Benzimidazole derivatives useful as tie-2 and/or vegfr-2 inhibitors
|
HUP0302526A2
(hu)
|
2000-12-21 |
2003-11-28 |
Glaxo Group Limited |
Makrolid vegyületek, eljárás az előállításukra, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
|
KR100362390B1
(ko)
|
2000-12-29 |
2002-11-23 |
삼성전자 주식회사 |
화상형성장치의 현상기-토너 카트리지 조립체
|
US7235576B1
(en)
|
2001-01-12 |
2007-06-26 |
Bayer Pharmaceuticals Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
JP2004532187A
(ja)
|
2001-01-25 |
2004-10-21 |
ギルフォード ファーマシュウティカルズ インコーポレイテッド |
三置換カルボサイクリックサイクロフィリン結合化合物とその用途
|
WO2002059081A2
(en)
|
2001-01-26 |
2002-08-01 |
Kirin Beer Kabushiki Kaisha |
Urea derivatives as inhibitors of ccr-3 receptor
|
FR2820136A1
(fr)
|
2001-01-26 |
2002-08-02 |
Aventis Pharma Sa |
Nouveaux derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et nouvelle utilisation
|
US6670364B2
(en)
|
2001-01-31 |
2003-12-30 |
Telik, Inc. |
Antagonists of MCP-1 function and methods of use thereof
|
ES2543383T3
(es)
|
2001-02-19 |
2015-08-18 |
Novartis Ag |
Tratamiento de tumores de mama con un derivado de rapamicina en combinación con exemestano
|
UA76977C2
(en)
|
2001-03-02 |
2006-10-16 |
Icos Corp |
Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers
|
US6525091B2
(en)
|
2001-03-07 |
2003-02-25 |
Telik, Inc. |
Substituted diarylureas as stimulators for Fas-mediated apoptosis
|
DE60221104T2
(de)
|
2001-03-07 |
2008-03-13 |
TELIK, INC., Palo Alto |
Substituierte diarylharnstoffe als stimulatoren der fas-vermittelten apoptose
|
AR035792A1
(es)
|
2001-03-23 |
2004-07-14 |
Bayer Corp |
Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
|
CA2443697A1
(en)
|
2001-04-13 |
2002-10-24 |
Pier F. Cirillo |
1,4-disubstituted benzo-fused compounds
|
CA2490819A1
(en)
|
2001-04-13 |
2002-10-24 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Compounds useful as anti-inflammatory agents
|
ES2283543T3
(es)
|
2001-04-20 |
2007-11-01 |
Bayer Pharmaceuticals Corporation |
Inhibicion de raf kinasa usando quinolil-, isoquinolil- o piridil ureas.
|
US7371763B2
(en)
|
2001-04-20 |
2008-05-13 |
Bayer Pharmaceuticals Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
US20030207914A1
(en)
|
2001-04-20 |
2003-11-06 |
Bayer Corporation |
Inhibition of raf kinase using quinolyl, isoquinolyl or pyridyl ureas
|
MXPA03009847A
(es)
|
2001-04-27 |
2004-02-12 |
Vertex Pharma |
Inhibidores de cinasa derivados de pirazol.
|
WO2002092576A1
(en)
|
2001-05-16 |
2002-11-21 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Diarylurea derivatives useful as anti-inflammatory agents
|
ATE360417T1
(de)
|
2001-07-11 |
2007-05-15 |
Boehringer Ingelheim Pharma |
Methode zur behandlung von zytokinvermittelten erkrankungen
|
US7371736B2
(en)
|
2001-11-07 |
2008-05-13 |
The Board Of Trustees Of The University Of Arkansas |
Gene expression profiling based identification of DKK1 as a potential therapeutic targets for controlling bone loss
|
SE0103838D0
(sv)
|
2001-11-16 |
2001-11-16 |
Astrazeneca Ab |
Pharmaceutical formulation & product
|
ES2275931T5
(es)
|
2001-12-03 |
2018-10-23 |
Bayer Healthcare Llc |
Compuestos de aril-urea en combinación con otros agentes citostáticos o citotóxicos para tratamiento de cánceres humanos
|
WO2003047523A2
(en)
*
|
2001-12-04 |
2003-06-12 |
Onyx Pharmaceuticals, Inc. |
Raf-mek-erk pathway inhibitors to treat cancer
|
ES1050706Y
(es)
|
2001-12-12 |
2002-08-16 |
Climastar Thermostone S L |
Convector electrico mejorado
|
CA2471114C
(en)
|
2001-12-21 |
2012-03-20 |
The Wellcome Trust |
Mutant b-raf polypeptide and a use thereof in the diagnosis of cancer
|
US20040096855A1
(en)
|
2001-12-24 |
2004-05-20 |
Michael Stratton |
Genes
|
WO2003060111A2
(en)
|
2001-12-24 |
2003-07-24 |
Catalyst Biomedica Limited |
Cancer-specific mutants of b-raf genes and uses thereof
|
US20030207872A1
(en)
|
2002-01-11 |
2003-11-06 |
Bayer Corporation |
Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US20080108672A1
(en)
|
2002-01-11 |
2008-05-08 |
Bernd Riedl |
Omega-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinase Inhibitors
|
AU2003207961A1
(en)
|
2002-01-16 |
2003-07-30 |
Ramot At Tel Aviv University Ltd. |
Compositions and their use for enhancing and inhibiting fertilization
|
WO2003062227A1
(en)
|
2002-01-23 |
2003-07-31 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
US6924290B2
(en)
|
2002-01-23 |
2005-08-02 |
Bayer Pharmaceuticals Corporation |
Rho-kinase inhibitors
|
US6998391B2
(en)
|
2002-02-07 |
2006-02-14 |
Supergen.Inc. |
Method for treating diseases associated with abnormal kinase activity
|
US7928277B1
(en)
|
2002-02-11 |
2011-04-19 |
Cox Jr Henry Wilmore |
Method for reducing contamination
|
JP4636486B2
(ja)
|
2002-02-11 |
2011-02-23 |
バイエル、ファーマシューテイカルズ、コーポレイション |
脈管形成阻害活性を有するアリール尿素
|
WO2003068229A1
(en)
|
2002-02-11 |
2003-08-21 |
Bayer Pharmaceuticals Corporation |
Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
|
ES2378670T3
(es)
|
2002-02-11 |
2012-04-16 |
Bayer Healthcare, Llc |
Aril ureas como inhibidores de cinasas
|
US7645878B2
(en)
*
|
2002-03-22 |
2010-01-12 |
Bayer Healthcare Llc |
Process for preparing quinazoline Rho-kinase inhibitors and intermediates thereof
|
US8299108B2
(en)
|
2002-03-29 |
2012-10-30 |
Novartis Ag |
Substituted benzazoles and methods of their use as inhibitors of raf kinase
|
TW200406374A
(en)
|
2002-05-29 |
2004-05-01 |
Novartis Ag |
Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases
|
EP1531817B1
(en)
|
2002-08-27 |
2008-07-30 |
MERCK PATENT GmbH |
Glycinamide derivatives as raf-kinase inhibitors
|
NZ538513A
(en)
|
2002-09-05 |
2007-02-23 |
Neurosearch As |
Diarylurea derivatives and their use as chloride channel blockers
|
KR20050071598A
(ko)
|
2002-10-24 |
2005-07-07 |
메르크 파텐트 게엠베하 |
라프-키나아제 억제제로서의 메틸렌 우레아 유도체
|
ES2421516T3
(es)
|
2002-11-06 |
2013-09-03 |
Dana Farber Cancer Inst Inc |
Composiciones para tratar el cáncer usando el inhibidor de proteasomas PS-341
|
AU2003283399B2
(en)
|
2002-11-15 |
2007-04-19 |
Novartis Ag |
Drug delivery system
|
SE0203654D0
(sv)
|
2002-12-09 |
2002-12-09 |
Astrazeneca Ab |
New compounds
|
US20030232400A1
(en)
|
2002-12-20 |
2003-12-18 |
Susan Radka |
Methods of screening subjects for expression of soluble receptors of vascular endothelial growth factor (VEGF) for use in managing treatment and determining prognostic outcome
|
US7202257B2
(en)
|
2003-12-24 |
2007-04-10 |
Deciphera Pharmaceuticals, Llc |
Anti-inflammatory medicaments
|
GB0317227D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Treatment of male sexual dysfunction
|
MXPA05009104A
(es)
|
2003-02-28 |
2006-05-31 |
Bayer Pharmaceuticals Corp |
Derivados de urea biciclica novedosa utiles en el tratamiento del cancer y otros trastornos.
|
ATE489379T1
(de)
|
2003-02-28 |
2010-12-15 |
Bayer Healthcare Llc |
2-oxo-1,3,5-perhydrotriazapinderivate, die sich zur behandlung von hyperproliferativen, angiogenen und entzündlichen erkrankungen eignen
|
US7557129B2
(en)
|
2003-02-28 |
2009-07-07 |
Bayer Healthcare Llc |
Cyanopyridine derivatives useful in the treatment of cancer and other disorders
|
MXPA05009102A
(es)
|
2003-02-28 |
2006-05-31 |
Bayer Pharmaceuticals Corp |
Derivados de piridina sustituida utiles en el tratamiento del cancer y otros trastornos.
|
US7531553B2
(en)
|
2003-03-21 |
2009-05-12 |
Amgen Inc. |
Heterocyclic compounds and methods of use
|
BRPI0407968A
(pt)
|
2003-03-24 |
2006-03-07 |
Merck Patent Gmbh |
derivados de oxamida úteis como inibidores de raf-quinase
|
US6896863B2
(en)
|
2003-04-01 |
2005-05-24 |
E. I. Du Pont De Nemours And Company |
Sodium cyanide process
|
PL1636585T3
(pl)
|
2003-05-20 |
2008-10-31 |
Bayer Healthcare Llc |
Diarylowe pochodne mocznika inhibowane kinazą
|
EP1636210A1
(en)
|
2003-06-05 |
2006-03-22 |
Warner-Lambert Company LLC |
Cycloalkyl and heterocycloalkyl substituted benzothiophenes as therapeutic agents
|
US20040259926A1
(en)
|
2003-06-05 |
2004-12-23 |
Bruendl Michelle M. |
3-Aryloxy and 3-heteroaryloxy substituted benzo[b]thiophenes as therapeutic agents
|
GB2403151A
(en)
|
2003-06-27 |
2004-12-29 |
Intermark Medical Innovations |
A device for rectal lavage
|
WO2005002673A1
(en)
|
2003-07-03 |
2005-01-13 |
Astex Therapeutics Limited |
Raf kinase inhibitors
|
JP4750701B2
(ja)
|
2003-07-07 |
2011-08-17 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
マロンアミド誘導体
|
US20060173033A1
(en)
|
2003-07-08 |
2006-08-03 |
Michaela Kneissel |
Use of rapamycin and rapamycin derivatives for the treatment of bone loss
|
WO2005016252A2
(en)
|
2003-07-11 |
2005-02-24 |
Ariad Gene Therapeutics, Inc. |
Phosphorus-containing macrocycles
|
CA2531859C
(en)
|
2003-07-11 |
2013-08-06 |
Merck Patent Gesellschaft Mit Beschraenkter Haftung |
Benzimidazole derivatives as raf kinase inhibitors
|
US7691870B2
(en)
|
2003-07-11 |
2010-04-06 |
Merck Patent Gmbh |
Benzimidazole carboxamides as raf kinase inhibitors
|
WO2005009367A2
(en)
|
2003-07-17 |
2005-02-03 |
Ambit Biosciences Corporation |
Treatment of diseases with kinase inhibitors
|
JP4777887B2
(ja)
|
2003-07-23 |
2011-09-21 |
バイエル、ファーマシューテイカルズ、コーポレイション |
病気および状態の処置および防止のためのフロロ置換オメガカルボキシアリールジフェニル尿素
|
GB0317229D0
(en)
|
2003-07-23 |
2003-08-27 |
Pfizer Ltd |
Improved process
|
AR045134A1
(es)
|
2003-07-29 |
2005-10-19 |
Smithkline Beecham Plc |
Compuesto de 1h - imidazo [4,5-c] piridin-ilo, composicion farmaceutica que lo comprende, proceso para prepararla, su uso para preparar dicha composicion farmaceutica, combinacion farmaceutica, uso de la combinacion farmaceutica para la preparacion de un medicamento, procedimientos para preparar dic
|
DE10334663A1
(de)
|
2003-07-30 |
2005-03-10 |
Merck Patent Gmbh |
Harnstoffderivate
|
BRPI0414698A
(pt)
|
2003-09-23 |
2006-11-28 |
Novartis Ag |
combinação de um inibidor receptor de vegf com um agente quimioterapêutico
|
DE10344223A1
(de)
|
2003-09-24 |
2005-04-21 |
Merck Patent Gmbh |
1,3-Benzoxazolylderivate als Kinase-Inhibitoren
|
WO2005040100A1
(en)
*
|
2003-10-15 |
2005-05-06 |
Bayer Healthcare Ag |
Tetrahydro-naphthalene and urea derivatives
|
CA2542329A1
(en)
|
2003-10-16 |
2005-04-28 |
Chiron Corporation |
2,6-disubstituted quinazolines, quinoxalines, quinolines and isoquinolines as inhibitors of raf kinase for treatment of cancer
|
ES2327418T3
(es)
|
2003-10-16 |
2009-10-29 |
Novartis Vaccines And Diagnostics, Inc. |
Benzazoles sustituidos y uso de los mismos como inhibidores de la quinasa raf.
|
DE10349587A1
(de)
|
2003-10-24 |
2005-05-25 |
Merck Patent Gmbh |
Benzimidazolylderivate
|
DE10352979A1
(de)
|
2003-11-13 |
2005-06-09 |
Merck Patent Gmbh |
Pyridopyrimidinone
|
US20050171172A1
(en)
|
2003-11-13 |
2005-08-04 |
Ambit Biosciences Corporation |
Amide derivatives as PDGFR modulators
|
DE10354060A1
(de)
|
2003-11-19 |
2005-06-02 |
Merck Patent Gmbh |
Pyrrolderivate
|
CN1889958A
(zh)
|
2003-12-09 |
2007-01-03 |
美国政府健康及人类服务部 |
抑制免疫应答或治疗增生性疾病的方法
|
JP2007515412A
(ja)
|
2003-12-10 |
2007-06-14 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフトング |
ジアシルヒドラジン誘導体
|
BRPI0507198A
(pt)
|
2004-01-30 |
2007-06-26 |
Merck Patent Gmbh |
derivados de bisariluréia
|
MXPA06010667A
(es)
|
2004-03-19 |
2007-07-04 |
Penn State Res Found |
Metodos combinatorios y composiciones para el tratamiento de melanoma.
|
EP1751139B1
(en)
|
2004-04-30 |
2011-07-27 |
Bayer HealthCare LLC |
Substituted pyrazolyl urea derivatives useful in the treatment of cancer
|
MY191349A
(en)
|
2004-08-27 |
2022-06-17 |
Bayer Pharmaceuticals Corp |
New pharmaceutical compositions for the treatment of hyper-proliferative disorders
|
ATE395905T1
(de)
|
2004-08-27 |
2008-06-15 |
Bayer Pharmaceuticals Corp |
Pharmazeutische zusammensetzungen in form fester dispersionen zur behandlung von krebs
|
CA2578384A1
(en)
|
2004-09-06 |
2006-03-16 |
Altana Pharma Ag |
Novel pyrazolopyrimidines
|
BRPI0515946A
(pt)
|
2004-09-29 |
2008-08-12 |
Bayer Healthcare Ag |
sal de tosilato, sua preparação e uso, bem como composição farmacêutica compreendendo o mesmo
|
PL1797037T3
(pl)
|
2004-09-29 |
2015-07-31 |
Bayer Healthcare Llc |
Sposób otrzymywania 4-{4-[({[4-chloro-3-(trifluorometylo)-fenylo]amino}karbonylo)amino]fenoksy}-N-metylopirydyno-2-karboksyamidu
|
US7625931B2
(en)
|
2005-01-14 |
2009-12-01 |
Cgi Pharmaceuticals, Inc. |
Certain substituted diphenyl ureas, as modulators of kinase activity
|
PL1868579T3
(pl)
|
2005-03-07 |
2011-03-31 |
Bayer Healthcare Llc |
Kompozycja farmaceutyczna zawierająca difenylomocznik podstawiony omega-karboksyarylem do leczenia nowotworu
|
DE102005015253A1
(de)
|
2005-04-04 |
2006-10-05 |
Merck Patent Gmbh |
Pyrazolderivate
|
CA2609389A1
(en)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Combination therapy comprising a diaryl urea compound and a pi3, akt kinase or mtor inhibitors (rapamycins) for cancer treatment
|
CA2609387A1
(en)
|
2005-05-27 |
2006-11-30 |
Bayer Healthcare Ag |
Combination therapy comprising diaryl ureas for treating diseases
|
EP1937837A2
(en)
|
2005-07-29 |
2008-07-02 |
Siemens Healthcare Diagnostics Inc. |
Methods and kits for the prediction of therapeutic success, recurrence free and overall survival in cancer therapies
|
CA2622673C
(en)
|
2005-09-21 |
2017-06-27 |
Thomas Maier |
Sulphonylpyrroles and use thereof as inhibitors of hdac s
|
KR20080073711A
(ko)
|
2005-10-21 |
2008-08-11 |
바이엘 헬스케어 엘엘씨 |
암의 예측 및 예후 방법, 및 암 치료 모니터링 방법
|
US8329408B2
(en)
*
|
2005-10-31 |
2012-12-11 |
Bayer Healthcare Llc |
Methods for prognosis and monitoring cancer therapy
|
US20090068146A1
(en)
*
|
2005-10-31 |
2009-03-12 |
Scott Wilhelm |
Diaryl ureas and combinations
|
EP1954272A2
(en)
|
2005-10-31 |
2008-08-13 |
Bayer Pharmaceuticals Corporation |
Treatment of cancer with sorafenib
|
JP2009515166A
(ja)
|
2005-11-02 |
2009-04-09 |
バイエル ヘルスケア エルエルシー |
がんの予測及び予後の検査方法、並びにがん治療のモニタリング
|
KR20080067000A
(ko)
|
2005-11-10 |
2008-07-17 |
바이엘 헬스케어 아게 |
폐 고혈압을 치료하기 위한 디아릴 우레아
|
JP5075832B2
(ja)
|
2005-11-10 |
2012-11-21 |
バイエル・ファルマ・アクチェンゲゼルシャフト |
肺高血圧を処置するためのジアリールウレア
|
CA2629863A1
(en)
|
2005-11-14 |
2007-05-24 |
Scott Wilhelm |
Use of sorafenib for the treatment of cancers with acquired resistance to kit inhibitors
|
US20070178494A1
(en)
|
2005-11-14 |
2007-08-02 |
James Elting |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
WO2007059155A1
(en)
|
2005-11-14 |
2007-05-24 |
Bayer Pharmaceuticals Corporation |
Treatment of cancers having resistance to chemotherapeutic agents
|
US20110195110A1
(en)
|
2005-12-01 |
2011-08-11 |
Roger Smith |
Urea compounds useful in the treatment of cancer
|
US20090227637A1
(en)
|
2005-12-15 |
2009-09-10 |
Olaf Weber |
Diaryl ureas for treating virus infections
|
JP2009524585A
(ja)
|
2005-12-15 |
2009-07-02 |
バイエル・ヘルスケア・アクチェンゲゼルシャフト |
ウイルス感染を処置するためのジアリールウレア
|
WO2007068380A1
(en)
|
2005-12-15 |
2007-06-21 |
Bayer Healthcare Ag |
Diaryl urea for treating virus infections
|
CA2634084C
(en)
|
2005-12-21 |
2015-04-07 |
Roger Smith |
Substituted pyrimidine derivatives useful in the treatment of cancer and other disorders
|
US20090197922A1
(en)
|
2006-01-24 |
2009-08-06 |
The University Of Chicago |
Compositions and methods for treating pulmonary hypertension
|
CA2648106A1
(en)
|
2006-03-31 |
2007-11-01 |
Bayer Healthcare Llc |
Methods for prediction and prognosis of cancer, and monitoring cancer therapy
|
EP2094268A2
(en)
|
2006-05-26 |
2009-09-02 |
Bayer HealthCare, LLC |
Drug combinations with substituted diaryl ureas for the treatment of cancer
|
AR062927A1
(es)
|
2006-10-11 |
2008-12-17 |
Bayer Healthcare Ag |
4- [4-( [ [ 4- cloro-3-( trifluorometil) fenil) carbamoil] amino] -3- fluorofenoxi) -n- metilpiridin-2- carboxamida monohidratada
|
JP2010509253A
(ja)
*
|
2006-11-09 |
2010-03-25 |
バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト |
4−[4−({[4−クロロ−3−(トリフルオロメチル)フェニル]カルバモイル}アミノ)−3−フルオロフェノキシ]−n−メチルピリジン−2−カルボキサミドの多形iii
|
WO2008055966A1
(en)
|
2006-11-09 |
2008-05-15 |
Abbott Gmbh & Co. Kg |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
WO2008058644A1
(en)
*
|
2006-11-14 |
2008-05-22 |
Bayer Schering Pharma Aktiengesellschaft |
Polymorph ii of 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-n-methylpyridine-2-carboxamide
|
CN101679362A
(zh)
|
2006-12-20 |
2010-03-24 |
拜尔保健公司 |
用于治疗癌症的 4 -{ 4 - [ ({ 3 -叔丁基 - 1 - [ 3 - (羟基甲基 )苯基 ] - 1 h -吡唑 - 5 -基} -氨基甲酰基)-氨基]-3-氟苯氧基}-n-甲基吡啶-2-甲酰氨及其前药和盐
|
US20100150863A1
(en)
|
2006-12-20 |
2010-06-17 |
Bayer Pharmaceuticals Corporation |
Hydroxy methyl phenyl pyrazolyl urea compound useful in treatment of cancer
|
JP2010516692A
(ja)
|
2007-01-19 |
2010-05-20 |
バイエル・ヘルスケア・エルエルシー |
化学療法剤に対し抵抗性を有する癌の処置
|
ES2429107T3
(es)
|
2007-01-19 |
2013-11-13 |
Bayer Healthcare Llc |
Tratamiento de cánceres con una resistencia adquirida a los agentes inhibidores de KIT
|
WO2008156024A1
(ja)
|
2007-06-21 |
2008-12-24 |
Sharp Kabushiki Kaisha |
光検出装置、及びそれを備えた表示装置
|
JP5076072B2
(ja)
|
2008-03-24 |
2012-11-21 |
矢崎総業株式会社 |
圧着端子、及びこの圧着端子を用いた圧着構造
|
EP2296641A1
(en)
|
2008-06-25 |
2011-03-23 |
Bayer Schering Pharma Aktiengesellschaft |
Diaryl urea for treating heart failure
|
JP5439494B2
(ja)
|
2008-10-21 |
2014-03-12 |
バイエル ヘルスケア エルエルシー |
肝細胞癌と関連するシグネチャ遺伝子の同定
|
JP5077375B2
(ja)
|
2010-02-26 |
2012-11-21 |
井関農機株式会社 |
コンバイン
|